Cancer screening and COVID-19 in Australia
Publication
Release Date:
Topic: Cancer screening
Citation
AIHW
Australian Institute of Health and Welfare (2021) Cancer screening and COVID-19 in Australia , AIHW, Australian Government, accessed 01 November 2024.
APA
Australian Institute of Health and Welfare. (2021). Cancer screening and COVID-19 in Australia . Canberra: AIHW.
MLA
Australian Institute of Health and Welfare. Cancer screening and COVID-19 in Australia . AIHW, 2021.
Vancouver
Australian Institute of Health and Welfare. Cancer screening and COVID-19 in Australia . Canberra: AIHW; 2021.
Harvard
Australian Institute of Health and Welfare 2021, Cancer screening and COVID-19 in Australia , AIHW, Canberra.
PDF | 1.8MB
This report looks at the impact of the COVID-19 pandemic on cancer screening in 2020, by presenting the number of screens between January and September 2020, and how these compare to the number of screens over the same period in the previous comparable year. The impact of COVID-19 was clearest for BreastScreen Australia: following a drop in screening mammograms in April 2020, the number of screening mammograms had returned to pre-COVID-19 numbers in September 2020.
- ISBN: 978-1-76054-820-9
- Cat. no: CAN 137
- Pages: 49
Findings from this report:
-
In April 2020, around 1,100 screening mammograms were performed, compared to more than 74,000 in April 2018
-
There were around 13,000 more screening mammograms performed In September 2020 than in September 2018
-
There were fewer cervical screening tests in 2020 but COVID-19 impact cannot yet be quantified due to program change
-
The number of bowel cancer screening tests did not clearly correspond with COVID-19 restrictions